Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Oana, Tudoran"'
Autor:
Oana Baldasici, Olga Soritau, Andrei Roman, Carmen Lisencu, Simona Visan, Laura Maja, Bogdan Pop, Bogdan Fetica, Andrei Cismaru, Laurian Vlase, Loredana Balacescu, Ovidiu Balacescu, Aman Russom, Oana Tudoran
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Cancer stem-like cells (CSCs) have been extensively researched as the primary drivers of therapy resistance and tumor relapse in patients with breast cancer. However, due to lack of specific molecular markers, increased phenotypic
Externí odkaz:
https://doaj.org/article/0078d5c4c5e44c268eece64cafeb7586
Autor:
Negar Abbasi Aval, Ekeram Lahchaichi, Oana Tudoran, Farzaneh Fayazbakhsh, Rainer Heuchel, Matthias Löhr, Torbjörn Pettersson, Aman Russom
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3061 (2023)
Three-dimensional (3D) tumor spheroids are regarded as promising models for utilization as preclinical assessments of chemo-sensitivity. However, the creation of these tumor spheroids presents challenges, given that not all tumor cell lines are able
Externí odkaz:
https://doaj.org/article/e1b8b66f39a349d582a1738207a46069
Autor:
Oana Baldasici, Loredana Balacescu, Daniel Cruceriu, Andrei Roman, Carmen Lisencu, Bogdan Fetica, Simona Visan, Andrei Cismaru, Ancuta Jurj, Lucian Barbu-Tudoran, Valentina Pileczki, Laurian Vlase, Oana Tudoran, Ovidiu Balacescu
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 20, p 12625 (2022)
Neo-adjuvant therapy (NAT) is increasingly used in the clinic for the treatment of breast cancer (BC). Pathological response to NAT has been associated with improved patients’ survival; however, the current techniques employed for assessing the tum
Externí odkaz:
https://doaj.org/article/76509f5f1d2a4f75955ad30bdb8a0568
Autor:
Lorena Alexandra Lisencu, Andrei Roman, Simona Visan, Eduard-Alexandru Bonci, Andrei Pașca, Emilia Grigorescu, Elena Mustea, Andrei Cismaru, Alexandru Irimie, Cosmin Lisencu, Loredana Balacescu, Ovidiu Balacescu, Oana Tudoran
Publikováno v:
Medicina, Vol 58, Iss 10, p 1494 (2022)
Background and Objectives: Prediction of response to therapy remains a continuing challenge in treating breast cancer, especially for identifying molecular tissue markers that best characterize resistant tumours. Microribonucleic acids (miRNA), known
Externí odkaz:
https://doaj.org/article/68e06fc3970a4f97a98a873b9212518d
Autor:
Oana Baldasici, Valentina Pileczki, Daniel Cruceriu, Laura Ioana Gavrilas, Oana Tudoran, Loredana Balacescu, Laurian Vlase, Ovidiu Balacescu
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 9371 (2022)
Metastasis represents the most important cause of breast cancer-associated mortality. Even for early diagnosed stages, the risk of metastasis is significantly high and predicts a grim outcome for the patient. Nowadays, efforts are made for identifyin
Externí odkaz:
https://doaj.org/article/2629b00b5dce43b8a2efd79e62ab8320
Autor:
Lorena Alexandra Lisencu, Sebastian Trancă, Eduard-Alexandru Bonci, Andrei Pașca, Carina Mihu, Alexandru Irimie, Oana Tudoran, Ovidiu Balacescu, Ioan Cosmin Lisencu
Publikováno v:
Biomedicines, Vol 10, Iss 4, p 769 (2022)
Breast cancer is one of the leading causes of death in women worldwide. One subtype of breast cancer is the triple-negative, which accounts for 15% of total breast cancer cases and is known for its poor prognosis. The main cause of death is due to me
Externí odkaz:
https://doaj.org/article/caf75899d0e142dab57626258401e6d9
Autor:
Carmen Lisencu, Oana Tudoran, Ovidiu Balacescu, Andrei Cismaru, Bogdan Fetica, Mircea Negrutiu, Cosmin Lisencu, Alexandru Irimie, Andrei Pasca, Andrei Roman, Lorena Alexandra Lisencu
Publikováno v:
Medicine and Pharmacy Reports.
Background and aims. Breast cancer (BC) is the most frequently diagnosed cancer and the leading cause of cancer-related death among women worldwide. For locally advanced diseases and high-risk tumors, neoadjuvant therapy (NAT) is the treatment of cho
Novel Strategies for the Improvement of Stem Cells’ Transplantation in Degenerative Retinal Diseases
Autor:
Simona Delia Nicoară, Sergiu Șușman, Oana Tudoran, Otilia Bărbos, Gabriela Cherecheș, Simion Aștilean, Monica Potara, Olga Sorițău
Publikováno v:
Stem Cells International, Vol 2016 (2016)
Currently, there is no cure for the permanent vision loss caused by degenerative retinal diseases. One of the novel therapeutic strategies aims at the development of stem cells (SCs) based neuroprotective and regenerative medicine. The main sources o
Externí odkaz:
https://doaj.org/article/e214d6a6678246c785a9f7ad76780d53
Autor:
Ovidiu Balacescu, Loredana Balacescu, Oana Virtic, Simona Visan, Claudia Gherman, Flaviu Drigla, Laura Pop, Gabriela Bolba-Morar, Carmen Lisencu, Bogdan Fetica, Oana Tudoran, Ioana Berindan-Neagoe
Publikováno v:
Mediators of Inflammation, Vol 2016 (2016)
Tumors act systemically to sustain cancer progression, affecting the physiological processes in the host and triggering responses in the blood circulating cells. In this study, we explored blood transcriptional patterns of patients with two subtypes
Externí odkaz:
https://doaj.org/article/ae31503c8598426f90df66f375c6d888
Publikováno v:
Seminars in cancer biology. 85
Hypoxia is arguably the first recognized cancer microenvironment hallmark and affects virtually all cellular populations present in tumors. During the past decades the complex adaptive cellular responses to oxygen deprivation have been largely elucid